Palisade bio announces enrollment and dosing of first patient in lb1148 dose optimization study

Study designed to determine if a different dosing protocol for all indications might enhance the risk profile of lb1148 while simultaneously providing effica cy
PALI Ratings Summary
PALI Quant Ranking